81363-14-6

Basic information

• Product Name: 1-(2,2,2-trifluoroethyl)piperidin-4-one
• Synonyms: 1-(2,2,2-trifluoroethyl)piperidin-4-one;UKRORGSYN-BB BBV-071437;1-(2,2,2-Trifluoroethyl)-4-piperidone
• CAS NO: 81363-14-6
• Molecular Formula: C₇H₁₀F₃NO
• Molecular Weight: 181.16
• Mol File: 81363-14-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-(2,2,2-trifluoroethyl)piperidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,2,2-trifluoroethyl)piperidin-4-one(81363-14-6)
• EPA Substance Registry System: 1-(2,2,2-trifluoroethyl)piperidin-4-one(81363-14-6)

Safety Data

• Hazardous Substances Data: 81363-14-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-(2,2,2-trifluoroethyl)piperidin-4-one is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure and properties make it a valuable component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(2,2,2-trifluoroethyl)piperidin-4-one serves as an intermediate in the production of agrochemicals. Its role in this industry is crucial for the development of effective and safe products for agricultural applications, such as pesticides and herbicides.
Used in Polymer Production:
1-(2,2,2-trifluoroethyl)piperidin-4-one is utilized as a building block in the creation of specialized polymers. Its incorporation into polymer structures can enhance their properties, such as stability, durability, and performance, making them suitable for various industrial applications.
Used in Chemical Compounds Synthesis:
1-(2,2,2-trifluoroethyl)piperidin-4-one is also used in the synthesis of various chemical compounds for different industrial applications. Its versatility and reactivity make it an essential component in the production of a wide range of products, from coatings and adhesives to specialty chemicals.

Upstream product

• 710350-66-6 8-(2,2,2-trifluoroethyl)-1,4-dioxa-8-azaspiro[4.5]-decane 
• 6226-25-1 2,2,2-trifluoroethyl trifluoromethanesulphonate 
• 41979-39-9 4-piperidone hydrochloride 
• 177-11-7 4,4-ethylenedioxy-piperidine 
• 176910-36-4 2,2,2-trifluoro-1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)ethan-1-one 

Downstream Products

• 187217-99-8 1-(2,2,2-trifluoroethyl)piperidin-4-ylamine 
• 1033844-86-8 1-(2,2,2-trifluoroethyl)-N-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]piperidin-4-amine 
• 1361570-83-3 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-N⁵-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]pyrimidine-4,5-diamine 
• 1361570-16-2 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]-7,9-dihydro-8H-purin-8-one 
• 90633-29-7 1-(2,2,2-trifluoroethyl)piperidin-4-ol 

Relevant articles and documents

1,5,7-TRISUBSTITUTED ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF IN MEDICINES

The present disclosure relates to 1,5,7-trisubstituted isoquinoline derivatives, their preparation and pharmaceutical use. In particular, the present disclosure discloses a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and a preparation method and use thereof. The definitions of the groups in the formula can be found in the specification and claims.

Lead Optimization toward Proof-of-Concept Tools for Huntington's Disease within a 4-(1 H -Pyrazol-4-yl)pyrimidine Class of Pan-JNK Inhibitors

Through medicinal chemistry lead optimization studies focused on calculated properties and guided by X-ray crystallography and computational modeling, potent pan-JNK inhibitors were identified that showed submicromolar activity in a cellular assay. Using in vitro ADME profiling data, 9t was identified as possessing favorable permeability and a low potential for efflux, but it was rapidly cleared in liver microsomal incubations. In a mouse pharmacokinetics study, compound 9t was brain-penetrant after oral dosing, but exposure was limited by high plasma clearance. Brain exposure at a level expected to support modulation of a pharmacodynamic marker in mouse was achieved when the compound was coadministered with the pan-cytochrome P450 inhibitor 1-aminobenzotriazole. (Chemical Presented)

Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors

The disclosure relates to compounds of formula (I): wherein R1-R5, A and Y are as defined in the disclosure, to compositions comprising said compounds, and to processes for making and methods of using the same.

Nicotinamide Derivatives

The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment o